Neuromedin U facilitates oxytocin release from the pituitary via β adrenoceptors

Authors:
  • NONobukazu Okada
    Nobukazu Okada
  • JIJunichi Ideno
    Junichi Ideno
  • AKAkio Kawakami
    Akio Kawakami
  • KHKazufumi Honda
    Kazufumi Honda
  • TYToshihiko Yada
    Toshihiko Yada
  • SIShun Ishibashi
    Shun Ishibashi

Abstract
Neuromedin U activates noradrenergic neurones in the medulla oblongata and oxytocin neurones in the hypothalamus. Here we examined roles of noradrenergic transmission in oxytocin release from the pituitary after intracerebroventricular administration of neuromedin U in rats. Neuromedin U administration facilitated noradrenaline release in the supraoptic nucleus. Administration of a beta1 adrenoceptor antagonist, metoprolol, or a beta2 antagonist, ICI 118551 but not an alpha1 antagonist, benoxathian, reduced increases in plasma oxytocin concentrations observed after administration of neuromedin U, but plasma ACTH concentrations were not significantly changed. All theses data suggest that neuromedin U stimulates oxytocin release from the pituitary, at least in part, via activation of beta adrenoceptors.

This publication has 23 references indexed in Scilit: